SBRA Stock Chart & Stats
$348.00
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$331.00 - $349.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
$98.59B
Enterprise Value$7.49K
Total Cash (Recent Filing)$123.45M
Total Debt (Recent Filing)$2.69B
Price to Earnings (P/E)34.7
Beta-0.02
Next Earnings
Aug 03, 2026EPS Estimate
2.99Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.64
Shares Outstanding252,190,100
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio1.60
Price to Book (P/B)1.62
Price to Sales (P/S)5.90
P/FCF Ratio13.11
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$394.26Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering13
EPS Forecast (FY)11.98
Revenue Forecast (FY)$15.53B
Bulls Say, Bears Say
Bulls Say
Robust Deal Pipeline And Accretive Investment ActivityA deep, accretive pipeline provides durable growth optionality: ongoing deal flow (~$400M closed/awarded YTD; large SHOP opportunities) allows Sabra to redeploy capital into higher-yielding senior housing and skilled assets, sustainably increasing cash NOI and supporting normalized FFO/AFFO over multiple quarters.
Improving Operating Results And Cash GenerationMaterial same-store NOI and FFO/AFFO gains reflect improving fundamentals: rising occupancy, RevPAR, and margin expansion point to durable demand and operational leverage in managed senior housing and triple-net portfolios, translating into more reliable cash flow conversion and stronger coverage of REIT distributions over the medium term.
Stronger Liquidity And Targeted Deleveraging ActionsImproved liquidity and explicit mortgage exit reduce refinancing risk and behavioral-health exposure: ~$1.2B available capital, lower permanent floating-rate exposure and proactive mortgage unwind improve funding optionality, enabling disciplined acquisitions and portfolio reshaping without immediate pressure on payout or forced disposals.
Bears Say
Elevated Leverage And Payout PressureA net debt/EBITDA around 5x and a dividend coverage near 77% reduce financial flexibility: sustained elevated leverage and a high payout ratio limit ability to absorb shocks, constrain reinvestment or opportunistic buyouts, and raise sensitivity to operating volatility or slower-than-expected pipeline returns over the coming quarters.
Highly Competitive, Tight Skilled Nursing Acquisition MarketPersistent competition in SNF transactions forces Sabra to bid tighter yields or forego deals: in a structurally constrained skilled nursing market, pressure from private buyers raises acquisition cap rates, compresses potential returns, and can slow accretive growth, making it harder to sustainably redeploy capital at target returns.
Behavioral-health Asset/legal Uncertainty And SHOP Occupancy PocketsOngoing legal/sale processes for behavioral-health assets create structural revenue uncertainty until resolved, and localized SHOP occupancy volatility indicates some markets remain unstable; both can reduce near-term cash NOI visibility and complicate portfolio optimization, affecting sustainable earnings and covenant headroom if outcomes are adverse.
Sabra Healthcare REIT News
SBRA FAQ
What was Sabra Healthcare Reit’s price range in the past 12 months?
Sabra Healthcare Reit lowest stock price was $331.00 and its highest was $349.00 in the past 12 months.
What is Sabra Healthcare Reit’s market cap?
Sabra Healthcare Reit’s market cap is $98.59B.
When is Sabra Healthcare Reit’s upcoming earnings report date?
Sabra Healthcare Reit’s upcoming earnings report date is Aug 03, 2026 which is in 9 days.
How were Sabra Healthcare Reit’s earnings last quarter?
Sabra Healthcare Reit released its earnings results on Apr 29, 2026. The company reported $2.801 earnings per share for the quarter, missing the consensus estimate of $2.819 by -$0.018.
Is Sabra Healthcare Reit overvalued?
According to Wall Street analysts Sabra Healthcare Reit’s price is currently Undervalued.
Does Sabra Healthcare Reit pay dividends?
Sabra Healthcare Reit does not currently pay dividends.
What is Sabra Healthcare Reit’s EPS estimate?
Sabra Healthcare Reit’s EPS estimate is 2.99.
How many shares outstanding does Sabra Healthcare Reit have?
Sabra Healthcare Reit has 252,190,100 shares outstanding.
What happened to Sabra Healthcare Reit’s price movement after its last earnings report?
Sabra Healthcare Reit reported an EPS of $2.801 in its last earnings report, missing expectations of $2.819. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Sabra Healthcare Reit?
Currently, no hedge funds are holding shares in MX:SBRA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Sabra Healthcare REIT Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$394.26 (― Downside)
$394.26 (― Downside)
Blogger Sentiment
Bullish
MX:SBRA Sentiment 70%
Sector Average 61%
Sector Average 61%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
27.22%
12-Months-Change
Fundamentals
Return on Equity
5.81%
Trailing 12-Months
Asset Growth
6.84%
Trailing 12-Months
Company Description
Sabra Healthcare Reit
Sabra Health Care REIT, Inc. engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.
SBRA Stock 12 Month Forecast
Average Price Target
$394.26